project id: TCGA-STAD; case submitter id: TCGA-KB-A6F7; selected normal wgs: true; source center: 23; state: released; a260 a280 ratio: 1.73; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.75; rna integrity number: 7.7; age at index: 54; days to birth: -19765; ethnicity: not reported; gender: female; race: not reported; vital status: Alive; year of birth: 1955; age at diagnosis: 19765; ajcc pathologic m: M0; ajcc pathologic n: N1; ajcc pathologic stage: Stage IB; ajcc pathologic t: T1; ajcc staging system edition: 6th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 1935.0; icd 10 code: C16.2; last known disease status: not reported; morphology: 8144/3; primary diagnosis: Adenocarcinoma, intestinal type; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Body of stomach; synchronous malignancy: No; tissue or organ of origin: Body of stomach; tumor grade: Not Reported; year of diagnosis: 2009; treatment or therapy: yes; alcohol history: Not Reported; is ffpe: false; weight: 10.0; composition: Not Reported; days to sample procurement: 0; initial weight: 50.0; portion submitter id: TCGA-KB-A6F7-01A-12; percent lymphocyte infiltration: 4.0; percent monocyte infiltration: 2.0; percent necrosis: 0.0; percent neutrophil infiltration: 6.0; percent normal cells: 0.0; percent stromal cells: 35.0; percent tumor cells: 65.0; percent tumor nuclei: 65.0;